BUSINESS

3 Generic Makers Ordered to Pay Damages over Oxarol Patent Infringement

July 28, 2017

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

Chugai Pharmaceutical said on July 27 that the Tokyo District Court ordered three generic makers of the company’s keratosis med Oxarol Ointment 25 µg/g (maxacalcitol) to pay damages over their patent infringements. In the ruling, Iwaki Seiyaku was ordered to…

To read the full story

Chugai Notches Supreme Court Victory in Oxarol Patent Suit
March 27, 2017
IP High Court Rules in Favor of Chugai in Oxarol Patent Suit
March 28, 2016
Chugai Wins First Round in Patent Infringement Lawsuit for Oxarol Ointment
December 26, 2014
Chugai Sues 4 Companies Including Iwaki Seiyaku for Patent Infringement Related to Oxarol Ointment
February 21, 2013

BUSINESS

Takeda Turns the Page to Kim’s “10-Year” Era, Betting on New Drugs and AI
June 26, 2026
Sangamo Files Chapter 11, Astellas and Lilly Eye Key Assets
June 26, 2026
Otsuka’s Centanafadine Meets PIII Goal in ADHD Patients with Anxiety
June 26, 2026
Shionogi Welcomes Government Roadmap’s Focus on Infectious Diseases
June 26, 2026
Sawai Cleared to Manufacture Nichi-Iko’s Lipitor Generic
June 26, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COLUMN

The Psychology of ‘Stuck’: Understanding Why Changing Jobs Feels So Hard

By Philip Carrigan

Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…

COMMENTARY

Adaptation, Diversification Key as Drug Wholesalers Face Profit Squeeze

By Tatsuya Otsuka

Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…